C3G Satellite Meeting

The Satellite Meeting will take place on Saturday, September 14th at the conference venue. There is a specific registration fee for the Satellite Meeting.

SATURDAY 14th SEPTEMBER
PLENARY ROOM
11:30 – 11:35 Welcome and Introduction – Richard Smith
11:35 – 12:15 Session One – C3 glomerulopathy in 2019: Where we are? – Chair: Miquel Blasco
12:15 – 13:30  Session Two: CAUSES: An update on pathogenesis – Chair: Elena Goicoechea de Jorge
13:30 – 14:30 Lunch and Networking
14:30 -16:00 Session Three: DIAGNOSIS: New insights – Chair: Carla Nester
16:00 – 16:30 Coffee Break and Networking
16:30 – 18:30  Session Four: TREATMENT: Trials on trial – Chair: Richard Smith
18:00-18:30  Meeting Close and Networking 

PROGRAM

11.30-11.35 Welcome and Introduction
Richard Smith
11.35-12.15 Session One: C3 glomerulopathy in 2019: Where we are?
Chair: Miquel Blasco
11.35-11.55 How we approach the condition and the patient in 2019
Marina Vivarelli
11.55-12.05 The current value of complement biomarkers in patient management
Joshua Thurman
12.05-12.15 The challenges and outcomes of transplantation
Moglie Le Quintrec
12.15-13.30 Session Two: CAUSES: An update on pathogenesis
Chair: Elena Goicoechea de Jorge
12.15-12.25 What is new from the mouse models
Kevin Marchbank
12.25-12.35 What’s new from mouse models: The C3del923_924DG mouse model
Santiago Rodríguez de Córdoba
12.35-12.50 Update on acquired factors: C3Nefs, antibodies and paraproteins – predicting outcome
Sophie Chauvet
12.50-13.00 Complement in the native and transplant kidney
Nicholas Medjeral-Thomas
13.00-13.30 Discussion of Sessions One and Two
Moderators: Miquel Blasco and Elena Goicoechea de Jorge
Panelists
13.30-14.30 Lunch and Networking
14.30-16.00 Session Three: DIAGNOSIS: New insights
Chair: Carla Nester
14.30-14.45 Influence of conventional immunosuppression in renal survival: insights from GLOSEN
Manuel Praga
14.45-15.00 Diagnostic Conundrums: do we need to refine the criteria to diagnose C3G?
Sanjeev Sethi
15.00-15.15 Complement, immunoglobulins and paraproteins: the variable expressions of C3 glomerulopathy
Veronique Fremeaux-Bacchi
15.15-15.30 Defining the clinical picture with complement biomarkers and assays
Richard Smith
15.30-16.00 Discussion of Session Three
Moderator: Carla Nester
Panelists
16.00-16.30 Coffee and Networking
16.30-18.00 Session Four: TREATMENT: Trials on trial
Chair: Richard Smith
16.30-16.50 The Doctor’s dilemma: The plethora of clinical trials: what to do
Richard Smith
16.50-17.10 The Patient’s perspective: Living with C3 glomerulopathy – messages from the patients
Lynne Lanning
17.10-17.30 Update on the trials
Carla Nester
17.30-18.00 Discussion of Session Four
Moderator: Richard Smith
Panelists
18.00-18.25 PHARMA Panel
Moderator: Carla Nester & Richard Smith
Panelists
Jason Cummings, PhD
Omeros Corporation
Guido Junge, MD, MBA
Novartis AG
Hetal Kocinsky, MD
Apellis Pharmaceuticals
Marc Uknis, MD
Achillion Pharmaceuticals

18.25-18.30 Final Thoughts and Conclusions
Richard Smith
18.30 Meeting Close and Networking
Contact us

Send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt